Team
Pierre Cordelier

ImPact :

Therapeutic innovation in pancreatic cancer

The specificities
of our research axis

Pancreatic cancer, or pancreatic adenocarcinoma (PDAC), will soon become the second leading cause of cancer deaths worldwide, due to late diagnosis and lack of effective treatment. Our research effort is dedicated to the development of new strategies to improve the management of patients with this cancer.

In this context, our research objective is to better understand the mechanisms of PDAC oncogenesis and therapeutic resistance. In particular, we are studying the role of genome remodelling and replication in gene expression and resistance to DNA-breaking agents (Project 1). We are deciphering the proteins and protein-protein interactions involved in pancreatic oncogenesis and resistance to treatment using intracellular antibodies (Project 2). Finally, we are investigating the mechanisms responsible for the resistance of cancer cells to oncolytic viruses, and studying the impact of these viruses on the anti-tumour immune response (Project 3).

The overall goal of this research project is to translate our basic research findings into tangible therapeutic innovations for pancreatic cancer patients, using a precision medicine approach.

Pancreatic Cancer

Oncogenesis

Resistance

Innovative therapies

Regulation of gene expression

Protein-protein interaction

Intracellular antibodies

Oncolytic viruses

Gene therapy

Immunotherapy

interdisciplinarity

research
projects

THE TEAM’S
FOCUS

Discover

Targeting the energy production process in pancreatic cancer cells, which relies on an enzyme called cytidine deaminase, could make these cells more vulnerablen ligase TRIP12 is required for pancreatic acinar cell plasticity and the development of pancreatic cancer.

Read More

The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and the development of pancreatic cancer.

Read More

An oncolytic virus with strong appetence for the most aggressive type of pancreatic cancer cells

Read More

Cytidine deaminase confers resistance to DNA-damaging drugs

Read More

Focus research 2022 ImPact team

Read More

Understand

Next news in English available soon

Read More

On the occasion of the World Cancer Day, digital round table “Toulouse: innovation in oncology (in french)

Read More

Participate

TOW2025 J-30 Earlybird registration

Read More

Research on pancreatic cancer: the FRAP project selected by INCa

Read More

The ImPact team is awarded the prestigious Fondation ARC label for 3 years

Read More

12th Summer School on Medicines

Read More

Live

CRCT-Oncopole Follow 1,433 1,279

Compte officiel du Centre de Recherches en Cancérologie de Toulouse

crctoncopole
Voir plus

scientific productions

PUBLICATIONS 2024
Maulat, Charlotte, Cindy Canivet, Bastien Cabarrou, Anne Pradines, Janick Selves, Anne Casanova, Aurélia Doussine, et al. “Prognostic Impact of Circulating Tumor DNA Detection in Portal and Peripheral Blood in Resected Pancreatic Ductal Adenocarcinoma Patients.” Scientific Reports 14, no. 1 (November 8, 2024): 27296. https://doi.org/10.1038/s41598-024-76903-y.
Frances, Audrey, Audrey Lumeau, Nicolas Bery, Marion Gayral, Lucille Stuani, Marie Sorbara, Estelle Saland, et al. “Cytidine Deaminase-Dependent Mitochondrial Biogenesis as a Potential Vulnerability in Pancreatic Cancer Cells.” Communications Biology 7, no. 1 (August 30, 2024): 1065. https://doi.org/10.1038/s42003-024-06760-y.
Brunet, Manon, Claire Vargas, Marjorie Fanjul, Damien Varry, Naïma Hanoun, Dorian Larrieu, Laetitia Pieruccioni, et al. “The E3 Ubiquitin Ligase TRIP12 Is Required for Pancreatic Acinar Cell Plasticity and Pancreatic Carcinogenesis.” The Journal of Pathology, June 25, 2024. https://doi.org/10.1002/path.6298.
Cornebois, Anaïs, Marie Sorbara, Margot Cristol, Emmanuelle Vigne, Pierre Cordelier, Klervi Desrumeaux, and Nicolas Bery. “Discovery of SOCS7 as a Versatile E3 Ligase for Protein-Based Degraders.” IScience 27, no. 5 (May 17, 2024): 109802. https://doi.org/10.1016/j.isci.2024.109802.
Lumeau, Audrey, Nicolas Bery, Audrey Francès, Marion Gayral, Guillaume Labrousse, Cyril Ribeyre, Charlene Lopez, et al. “Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.” Cancer Research 84, no. 7 (April 1, 2024): 1013–28. https://doi.org/10.1158/0008-5472.CAN-22-3219.
Vienne, Margaux, Charlène Lopez, Hubert Lulka, Adèle Nevot, Guillaume Labrousse, Nelson Dusetti, Louis Buscail, and Pierre Cordelier. “Minute Virus of Mice Shows Oncolytic Activity against Pancreatic Cancer Cells Exhibiting a Mesenchymal Phenotype.” Molecular Therapy. Oncology 32, no. 1 (March 21, 2024): 200780. https://doi.org/10.1016/j.omton.2024.200780.
Nicolle, Rémy, Cindy Canivet, Laurent Palazzo, Bertrand Napoléon, Mira Ayadi, Camille Pignolet, Jérôme Cros, et al. “Predictive Genomic and Transcriptomic Analysis on Endoscopic Ultrasound-Guided Fine Needle Aspiration Materials from Primary Pancreatic Adenocarcinoma: A Prospective Multicentre Study.” EBioMedicine 109 (2024): 105373. https://doi.org/10.1016/j.ebiom.2024.105373.
PUBLICATIONS 2023
Keyan, Kripa S., Safa Salim, Swetha Gowda, Doua Abdelrahman, Syeda Sakina Amir, Zeyaul Islam, Claire Vargas, et al. “Control of TGFβ Signalling by Ubiquitination Independent Function of E3 Ubiquitin Ligase TRIP12.” Cell Death & Disease 14, no. 10 (October 20, 2023): 692. https://doi.org/10.1038/s41419-023-06215-y.
Barbey, Odile, Hubert Lulka, Naima Hanoun, Hafid Belhadj-Tahar, Fabienne Vernejoul, Gilles Cambois, Michèle Tiraby, Louis Buscail, Fabian Gross, and Pierre Cordelier. “Preclinical Development of Non-Viral Gene Therapy for Patients with Advanced Pancreatic Cancer.” Molecular Therapy. Methods & Clinical Development 29 (June 8, 2023): 162–72. https://doi.org/10.1016/j.omtm.2023.03.005.
Le Cosquer, Guillaume, Charlotte Maulat, Barbara Bournet, Pierre Cordelier, Etienne Buscail, and Louis Buscail. “Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach.” Cancers 15, no. 3 (January 26, 2023): 761. https://doi.org/10.3390/cancers15030761.
PUBLICATIONS 2022
Quillien, Lorraine, Louis Buscail, and Pierre Cordelier. “Pancreatic Cancer Cell and Gene Biotherapies; Past, Present and Future.” Human Gene Therapy, December 31, 2022. https://doi.org/10.1089/hum.2022.210.
Chaves-Almagro, Carline, Johanna Auriau, Alizée Dortignac, Pascal Clerc, Hubert Lulka, Simon Deleruyelle, Fabrice Projetti, et al. “Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development.” International Journal of Molecular Sciences 23, no. 18 (September 13, 2022): 10600. https://doi.org/10.3390/ijms231810600.
Keller, Laura, Claudine Tardy, Laetitia Ligat, Soazig Le Pennec, Nicolas Bery, Faten Koraïchi, Patrick Chinestra, et al. “Tripartite Split-GFP Assay to Identify Selective Intracellular Nanobody That Suppresses GTPase RHOA Subfamily Downstream Signaling.” Frontiers in Immunology 13 (August 18, 2022): 980539. https://doi.org/10.3389/fimmu.2022.980539.
Sorbara, Marie, Pierre Cordelier, and Nicolas Bery. “Antibody-Based Approaches to Target Pancreatic Tumours.” Antibodies 11, no. 3 (July 12, 2022): 47. https://doi.org/10.3390/antib11030047.
Cordelier, Pierre, Manon Costa, and Jérôme Fehrenbach. “Slow-Fast Model and Therapy Optimization for Oncolytic Treatment of Tumors.” Bulletin of Mathematical Biology 84, no. 6 (May 10, 2022): 64. https://doi.org/10.1007/s11538-022-01025-3.
Bery, Nicolas, and Terry H. Rabbitts. “A Cell-Based Screening Method Using an Intracellular Antibody for Discovering Small Molecules Targeting Hard-to-Drug Proteins.” Bio-Protocol 12, no. 4 (February 20, 2022): e4324. https://doi.org/10.21769/BioProtoc.4324.
Buscail, Louis. “[Pancreatic tumors: a hierarchical diagnostic and therapeutic].” La Revue Du Praticien 72, no. 2 (February 2022): 210.
Rouanet, Marie, Naima Hanoun, Hubert Lulka, Cindy Ferreira, Pierre Garcin, Martin Sramek, Godefroy Jacquemin, et al. “The Antitumoral Activity of TLR7 Ligands Is Corrupted by the Microenvironment of Pancreatic Tumors.” Molecular Therapy, January 2022, S1525001622000181. https://doi.org/10.1016/j.ymthe.2022.01.018.
PUBLICATIONS 2021
Marinho, Anthony, Nicolas Zalay, Léonor Chaltiel, Sylvain Kirzin, Antoine Philis, Jannick Selves, Nicolas Carrère, Etienne Buscail, and Laurent Ghouti. “Oncologic and Functional Outcomes of Pelvic Perineal Reconstruction by Perineal Colostomy and Malone Procedure After Abdominoperineal Resection.” Diseases of the Colon and Rectum 64, no. 12 (December 1, 2021): 1501–10. https://doi.org/10.1097/DCR.0000000000001941.
Sorbara, Marie, and Nicolas Bery. “Targeting Small GTPases and Their Downstream Pathways with Intracellular Macromolecule Binders to Define Alternative Therapeutic Strategies in Cancer.” Biochemical Society Transactions 49, no. 5 (November 1, 2021): 2021–35. https://doi.org/10.1042/BST20201059.
Thibault, Benoit, Fernanda Ramos-Delgado, Elvire Pons-Tostivint, Nicole Therville, Celia Cintas, Silvia Arcucci, Stephanie Cassant-Sourdy, et al. “Pancreatic Cancer Intrinsic PI3Kα Activity Accelerates Metastasis and Rewires Macrophage Component.” EMBO Molecular Medicine 13, no. 7 (July 7, 2021): e13502. https://doi.org/10.15252/emmm.202013502.
Montfort, Anne, Florie Bertrand, Julia Rochotte, Julia Gilhodes, Thomas Filleron, Jean Milhès, Carine Dufau, et al. “Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.” Cancer Immunology Research 9, no. 5 (May 2021): 568–82. https://doi.org/10.1158/2326-6066.CIR-20-0342.
Tijunelyte, Inga, Rémi Malbec, Bayan Chami, Jean Cacheux, Christophe Dez, Thierry Leichlé, Pierre Cordelier, and Aurélien Bancaud. “Micro-RNA 21 Detection with a Limit of 2 PM in 1 Min Using a Size-Accordable Concentration Module Operated by Electrohydrodynamic Actuation.” Biosensors & Bioelectronics 178 (April 15, 2021): 112992. https://doi.org/10.1016/j.bios.2021.112992.
Quillien, Lorraine, Sokunthea Top, Sandrine Kappler-Gratias, Agathe Redouté, Nelson Dusetti, Charlotte Quentin-Froignant, Hubert Lulka, et al. “A Novel Imaging Approach for Single-Cell Real-Time Analysis of Oncolytic Virus Replication and Efficacy in Cancer Cells.” Human Gene Therapy 32, no. 3–4 (February 2021): 166–77. https://doi.org/10.1089/hum.2020.294.
PUBLICATIONS 2020
Frere, Corinne, Benjamin Crichi, Barbara Bournet, Cindy Canivet, Nassim Ait Abdallah, Louis Buscail, and Dominique Farge. “Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Cancers 12, no. 8 (July 24, 2020): 2028. https://doi.org/10.3390/cancers12082028.
Amintas, Samuel, Aurélie Bedel, François Moreau-Gaudry, Julian Boutin, Louis Buscail, Jean-Philippe Merlio, Véronique Vendrely, Sandrine Dabernat, and Etienne Buscail. “Circulating Tumor Cell Clusters: United We Stand Divided We Fall.” International Journal of Molecular Sciences 21, no. 7 (April 10, 2020): E2653. https://doi.org/10.3390/ijms21072653.
Maulat, Charlotte, Cindy Canivet, Célia Touraine, Sophie Gourgou, Bertrand Napoleon, Laurent Palazzo, Nicolas Flori, et al. “A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score.” Cancers 12, no. 4 (March 25, 2020): 783. https://doi.org/10.3390/cancers12040783.
Frances, Audrey, and Pierre Cordelier. “The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?” Molecular Therapy: The Journal of the American Society of Gene Therapy, February 5, 2020. https://doi.org/10.1016/j.ymthe.2019.11.026.
Buscail, Louis, Barbara Bournet, and Pierre Cordelier. “Role of Oncogenic KRAS in the Diagnosis, Prognosis and Treatment of Pancreatic Cancer.” Nature Reviews. Gastroenterology & Hepatology, January 31, 2020. https://doi.org/10.1038/s41575-019-0245-4.
Larrieu, D., M. Brunet, C. Vargas, N. Hanoun, L. Ligat, L. Dagnon, H. Lulka, et al. “The E3 Ubiquitin Ligase TRIP12 Participates in Cell Cycle Progression and Chromosome Stability.” Scientific Reports 10, no. 1 (January 21, 2020): 789. https://doi.org/10.1038/s41598-020-57762-9.
Lumeau, Audrey, and Pierre Cordelier. “One Two Punch: Combination Chemotherapy Knocks Out Pancreatic Cancer.” Molecular Therapy 28, no. 8 (2020): 1751–52. https://doi.org/10.1016/j.ymthe.2020.07.014.
Nicolle, Rémy, Yuna Blum, Pauline Duconseil, Charles Vanbrugghe, Nicolas Brandone, Flora Poizat, Julie Roques, et al. “Establishment of a Pancreatic Adenocarcinoma Molecular Gradient (PAMG) That Predicts the Clinical Outcome of Pancreatic Cancer.” EBioMedicine 57 (2020): 102858. https://doi.org/10.1016/j.ebiom.2020.102858.
Frere, Corinne, Barbara Bournet, Sophie Gourgou, Julien Fraisse, Cindy Canivet, Jean M. Connors, Louis Buscail, et al. “Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.” Gastroenterology 158, no. 5 (2020): 1346-1358.e4. https://doi.org/10.1053/j.gastro.2019.12.009.
Amintas, Samuel, Véronique Vendrely, Charles Dupin, Louis Buscail, Christophe Laurent, Barbara Bournet, Jean-Philippe Merlio, et al. “Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA.” Frontiers in Cell and Developmental Biology 8 (2020): 622048. https://doi.org/10.3389/fcell.2020.622048.
PUBLICATIONS 2019
Diaz-Riascos, Zamira Vanessa, Mireia M. Ginesta, Joan Fabregat, Teresa Serrano, Juli Busquets, Louis Buscail, Pierre Cordelier, and Gabriel Capellá. “Expression and Role of MicroRNAs from the MiR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer.” Molecular Therapy. Nucleic Acids 17 (June 29, 2019): 491–503. https://doi.org/10.1016/j.omtn.2019.06.015.
Buscail, Etienne, Charlotte Maulat, Fabrice Muscari, Laurence Chiche, Pierre Cordelier, Sandrine Dabernat, Catherine Alix-Panabières, and Louis Buscail. “Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma.” Cancers 11, no. 6 (June 19, 2019). https://doi.org/10.3390/cancers11060852.
Dromain, Clarisse, Marianne E. Pavel, Philippe Ruszniewski, Alison Langley, Christine Massien, Eric Baudin, Martyn E. Caplin, and CLARINET Study Group. “Tumor Growth Rate as a Metric of Progression, Response, and Prognosis in Pancreatic and Intestinal Neuroendocrine Tumors.” BMC Cancer 19, no. 1 (January 14, 2019): 66. https://doi.org/10.1186/s12885-018-5257-x.
Cacheux, Jean, Aurélien Bancaud, Thierry Leichlé, and Pierre Cordelier. “Technological Challenges and Future Issues for the Detection of Circulating MicroRNAs in Patients With Cancer.” Frontiers in Chemistry 7 (2019): 815. https://doi.org/10.3389/fchem.2019.00815.

team members

Léa Badin
Ingénieur de laboratoire / laboratory engineer
Noémie Delenclos
Master / Master student
Margot Cristol
Master / Master student
Laura Jouvin
Doctorant / PhD student
Nina Suarez
Ingénieur de laboratoire / laboratory engineer
Jean Cacheux
Chercheur Post-Doctorant / Post-Doc researcher
Alban Ricard
Doctorant / PhD student
Damien Varry
Doctorant / PhD student
Barbara Bournet
Hospitalo-Universitaire / University teacher hospital practitioner
Nicolas Carrère
Hospitalo-Universitaire / University teacher hospital practitioner
Charlotte Maulat
Doctorant / PhD student
Louis Buscail
Hospitalo-Universitaire / University teacher hospital practitioner
Fabrice Muscari
Enseignant chercheur / University researcher
Jérôme Torrisani
Chercheur statutaire / permanent scientist
Nikolaos Kontopoulos
Doctorant / PhD student
Pierre Cordelier
Chercheur statutaire / permanent scientist
Agathe Redouté
Doctorant / PhD student
Marie Sorbara
Doctorant / PhD student
Naïma Hanoun-Ziane
Ingénieur de laboratoire / laboratory engineer
Nicolas Béry
Chercheur statutaire / permanent scientist

partnerships & Funding

Centre de Recherches en Cancérologie de Toulouse

Toulouse Cancer Research Center (Oncopole)

Toulouse - FR

Contact us

+33 5 82 74 15 75

Contact us

Want to join
the CRCT team ?

Join-us

Pin It on Pinterest